Inventor
Michel Gallant
Inventor
Pierrefonds, CA
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds8%
Y02ATechnologies for adaptation to climate change8%
C07HSugars7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C12NMicroorganisms or enzymes3%
C07KPeptides1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,913,7612,7-dibromospiro[fluorene-9,4'-piperidine] compounds202110,669,298Mannose derivatives for treating bacterial infections202010,407,414Mannose derivatives for treating bacterial infections20199,963,478Mannose derivatives for treating bacterial infections20189,890,176'Mannose derivatives for treating bacterial infections'20189,598,454'Mannose derivatives for treating bacterial infections'20178,637,671'Indole derivatives as CRTH2 receptor antagonists'20148,343,968'Case of renin inhibitors'20138,334,308'Renin inhibitors'20128,076,359'Renin inhibitors'20118,063,105'Renin inhibitors'20117,622,501'Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors'20097,482,456'8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors'20097,342,024'4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors'20087,238,706'4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors'20077,153,968'8-(biaryl)quinoline PDE4 inhibitors'20067,144,896'Hetero-bridge substituted 8-arylquinoline pde4 inhibitors'20066,919,353'Substituted 8-arylquinolune PDE4 inhibitors'20056,627,656'Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore'20036,410,563'Substituted 8-arylquinoline phosphodiesterase-4 inhibitors'20026,242,493'Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment'20016,211,197'Prostaglandin receptor ligands'20015,834,228'Method for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complex'19985,798,442'Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases'19985,532,237'Indole derivatives with affinity for the cannabinoid receptor'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2009Patents assigned to MERCK FROSST CANADA INC (8)· patent assignee history
1996–2008Based in Montreal, CA· patent location history
2001–2021Based in Pierrefonds, CA· patent location history
2001–2002Based in Montreal-Quest, CA· patent location history
2009–2011Based in Kirkland, CA· patent location history
2011–2014Patents assigned to GALLANT MICHEL (5)· patent assignee history
2011–2013Patents assigned to DUBE DANIEL (4)· patent assignee history
2011–2014Patents assigned to MERCK CANADA INC (4)· patent assignee history
2012Based in Pierre Fonds, CA· patent location history
2017–2021Patents assigned to VERTEX PHARMA (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK FROSST CANADA INC | 8 | 1996–2009 |
| VERTEX PHARMA | 6 | 2017–2021 |
| GALLANT MICHELself | 5 | 2011–2014 |
| DUBE DANIEL | 4 | 2011–2013 |
| MERCK CANADA INC | 4 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pierrefonds, CA | 9 | 2001–2021 |
| Montreal, CA | 8 | 1996–2008 |
| Kirkland, CA | 3 | 2009–2011 |
| Montreal-Quest, CA | 2 | 2001–2002 |
| Pierre Fonds, CA | 1 | 2012 |